Literature summary for 3.4.22.38 extracted from

Wendling, D.; Cedoz, J.P.; Racadot, E.
Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: effect of TNFalpha antagonist therapy (2008), Joint Bone Spine, 75, 559-562.

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Source Tissue	Comment	Organism	Textmining
serum	cathepsin K levels are not significantly increased in serum of patients with ankylosing spondylitis, 6.41 pg/ml in patients and 3.64 pg/ml in healthy controls, overview	Homo sapiens	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)